A one-of-a-kind pitch competition designed to help showcase and support the best pediatric healthcare innovations, Impact Pediatric Health has announced an open call for submissions through Friday, Feb. 6.

A local CHOP-based consortium announces grants to develop pediatric medical tools — one to reduce pain in a medical procedure, another to reduce antibiotic overuse.

CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.

Zion Harvey received a double hand transplant at The Children's Hospital of Philadelphia — first child to undergo this procedure. Zion received OT and PT several times a day during his recovery.

The Children's Hospital of Philadelphia’s Division of Pediatric Ophthalmology welcomes neuro-ophthalmologist Robert A. Avery, DO, MSCE.

An international survey finds gap in knowledge when dealing with child traumatic stress.

Spark Therapeutics, Inc. recently announced a public offering issuing two-million primary shares at $47.00 per share. Included in the sale as a secondary offering are one-million shares, at $47.00, held by CHOP.

The Children’s Hospital of Philadelphia has chosen Douglas G. Hock as its new executive vice president and chief operating officer, beginning on Feb. 1.

A $1.5 million grant to CHOP from Alex’s Lemonade Stand Foundation supports an innovative treatment for children with high-risk neuroblastoma.

By any measure, 8-year-old Zion Harvey has led an extraordinary life. At the age of 2, he developed sepsis, a life-threatening infection that led to the amputation of his feet and hands. The illness also damaged his kidneys and, two years later, Zion underwent a kidney transplant — receiving an organ donated by his mother, Pattie Ray.